Costs of Antifungal Prophylaxis After Bone Marrow Transplantation: A Model Comparing Oral Fluconazole, Liposomal Amphotericin and Oral Polyenes as Prophylaxis Against Oropharyngeal Infections

Alan Stewart*, Ray Powles, Margaret Hewetson, Judy Antrum, Celia Richardson, Jayesh Mehta

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

The costs per successfully treated patient over a 12-week period were £28 956 (£1 = $US 1.60, June 1995) for oral fluconazole, £53 225 for liposomal amphotericin and £32 768 for oral polyenes. Sensitivity analysis showed that the costs of liposomal amphotericin always exceeded those of the oral comparators, reflecting its high acquisition, preparation and administration costs.

Original languageEnglish (US)
Pages (from-to)350-361
Number of pages12
JournalPharmacoEconomics
Volume8
Issue number4
DOIs
StatePublished - Oct 1995

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy
  • Public Health, Environmental and Occupational Health

Fingerprint Dive into the research topics of 'Costs of Antifungal Prophylaxis After Bone Marrow Transplantation: A Model Comparing Oral Fluconazole, Liposomal Amphotericin and Oral Polyenes as Prophylaxis Against Oropharyngeal Infections'. Together they form a unique fingerprint.

Cite this